BD, CerTest Biotec Announce US Commercial Launch of Monkeypox Assay

FRANKLIN LAKES, N.J., Sept. 26, 2022 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and CerTest Biotec today announced their newly developed molecular polymerase chain reaction (PCR) assay for monkeypox virus is now commercially available globally, including in the United States, for research use only applications by laboratories. […]

Read More

BioHive Women in STEM Event recap

BioHive continued its celebration of “STEM September” with the Women in STEM Mingle in downtown Salt Lake City on Tuesday night. Over 65 life science professionals were in attendance to connect with the industry and support the efforts of BioHive.  As a collective, event attendees assembled and packed over 475 Math Learning Kits for Granite […]

Read More

2022 Biosphere Magazine Now Available

Each year, BioUtah publishes a special Utah life sciences magazine, Biosphere, released with the September issue of Utah Business Magazine. The 2022 iteration of Biosphere focuses on the incredible innovation taking place within Utah’s life sciences industry.  From Intermountain’s evolution beyond health care delivery to become a life sciences powerhouse within Utah to innovation happening within […]

Read More

Recruitment for Non-Invasive Parkinson’s Pivotal Study Slated for December

Non-invasive Parkinson’s therapeutic device moves one step closer to FDA clearance, with important potential non-motor and motor improvements for patients. The maker of the widely anticipated Celeste® specialized phototherapy device, PhotoPharmics, today announced plans to begin recruitment for the Celeste Light for PD trial in December. “Multiple forces have aligned to make the timing for […]

Read More

Inherent Biosciences raises Series A funding led by Propel Bio Partners to redefine the path to parenthood by elevating the standard of care in male reproductive health

Salt Lake City, Utah /PRNewswire/ — Inherent Biosciences, the first Utah company involved in commercializing a diagnostic in the emerging biotech field of epigenetics, has raised Series A funding from an investor group led by Los Angeles-based Propel Bio Partners toward Inherent’s goal of changing the course of reproductive health. Inherent seeks to redefine the […]

Read More